• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

早幼粒细胞白血病的两次关键打击。

Two critical hits for promyelocytic leukemia.

作者信息

He L Z, Bhaumik M, Tribioli C, Rego E M, Ivins S, Zelent A, Pandolfi P P

机构信息

Department of Human Genetics and Molecular Biology Program Memorial Sloan-Kettering Cancer Center Sloan-Kettering Institute, New York, NY 10021, USA.

出版信息

Mol Cell. 2000 Nov;6(5):1131-41. doi: 10.1016/s1097-2765(00)00111-8.

DOI:10.1016/s1097-2765(00)00111-8
PMID:11106752
Abstract

Acute promyelocytic leukemia (APL) is associated with chromosomal translocations that always involve the RARalpha gene, which variably fuses to one of several distinct loci, including PML or PLZF (X genes). Due to the reciprocity of the translocation, X-RARalpha and RARalpha-X fusion proteins coexist in APL blasts. PLZF-RARalpha transgenic mice (TM) develop leukemia that lacks the differentiation block at the promyelocytic stage that characterizes APL. We generated TM expressing RARalpha-PLZF and PLZF-RARalpha in their promyelocytes. RARalpha-PLZF TM do not develop leukemia. However, PLZF-RARalpha/RARalpha-PLZF double TM develop leukemia with classic APL features. We demonstrate that RARalpha-PLZF can interfere with PLZF transcriptional repression and that this is critical for APL pathogenesis, since leukemias in PLZF(-/-)/PLZF-RARalpha mutants and in PLZF-RARalpha/RARalpha-PLZF TM are indistinguishable. Thus, both products of a cancer-associated translocation are crucial in determining the distinctive features of the disease.

摘要

急性早幼粒细胞白血病(APL)与染色体易位相关,这些易位总是涉及RARα基因,该基因可与几个不同的位点之一发生可变融合,包括PML或PLZF(X基因)。由于易位的相互性,X-RARα和RARα-X融合蛋白在APL原始细胞中共存。PLZF-RARα转基因小鼠(TM)会发生白血病,其在早幼粒细胞阶段缺乏APL特有的分化阻滞。我们在其早幼粒细胞中生成了表达RARα-PLZF和PLZF-RARα的TM。RARα-PLZF TM不会发生白血病。然而,PLZF-RARα/RARα-PLZF双转基因小鼠会发生具有典型APL特征的白血病。我们证明RARα-PLZF可以干扰PLZF的转录抑制,并且这对APL发病机制至关重要,因为PLZF(-/-)/PLZF-RARα突变体和PLZF-RARα/RARα-PLZF TM中的白血病难以区分。因此,癌症相关易位的两种产物对于确定疾病的独特特征都至关重要。

相似文献

1
Two critical hits for promyelocytic leukemia.早幼粒细胞白血病的两次关键打击。
Mol Cell. 2000 Nov;6(5):1131-41. doi: 10.1016/s1097-2765(00)00111-8.
2
Reduced retinoic acid-sensitivities of nuclear receptor corepressor binding to PML- and PLZF-RARalpha underlie molecular pathogenesis and treatment of acute promyelocytic leukemia.核受体共抑制因子与早幼粒细胞白血病(PML)及早幼粒细胞白血病锌指蛋白(PLZF)-维甲酸受体α(RARα)结合时视黄酸敏感性降低是急性早幼粒细胞白血病分子发病机制及治疗的基础。
Blood. 1998 Apr 15;91(8):2634-42.
3
Distinct leukemia phenotypes in transgenic mice and different corepressor interactions generated by promyelocytic leukemia variant fusion genes PLZF-RARalpha and NPM-RARalpha.转基因小鼠中不同的白血病表型以及早幼粒细胞白血病变异融合基因PLZF-RARα和NPM-RARα产生的不同共抑制因子相互作用。
Proc Natl Acad Sci U S A. 1999 May 25;96(11):6318-23. doi: 10.1073/pnas.96.11.6318.
4
Down-stream regions of the POZ-domain influence the interaction of the t(11;17)-associated PLZF/RARalpha fusion protein with the histone-deacetylase recruiting co-repressor complex.POZ结构域的下游区域影响与t(11;17)相关的PLZF/RARα融合蛋白与募集组蛋白去乙酰化酶的共抑制复合物之间的相互作用。
Hematol J. 2001;2(6):385-92. doi: 10.1038/sj.thj.6200138.
5
Distinct interactions of PML-RARalpha and PLZF-RARalpha with co-repressors determine differential responses to RA in APL.PML-RARα和PLZF-RARα与共抑制因子的不同相互作用决定了急性早幼粒细胞白血病(APL)对维甲酸(RA)的不同反应。
Nat Genet. 1998 Feb;18(2):126-35. doi: 10.1038/ng0298-126.
6
Retinoic acid (RA) and As2O3 treatment in transgenic models of acute promyelocytic leukemia (APL) unravel the distinct nature of the leukemogenic process induced by the PML-RARalpha and PLZF-RARalpha oncoproteins.在急性早幼粒细胞白血病(APL)转基因模型中,视黄酸(RA)和三氧化二砷(As2O3)治疗揭示了由PML-RARα和PLZF-RARα癌蛋白诱导的白血病发生过程的独特性质。
Proc Natl Acad Sci U S A. 2000 Aug 29;97(18):10173-8. doi: 10.1073/pnas.180290497.
7
Fusion proteins of the retinoic acid receptor-alpha recruit histone deacetylase in promyelocytic leukaemia.维甲酸受体-α融合蛋白在早幼粒细胞白血病中募集组蛋白脱乙酰基酶。
Nature. 1998 Feb 19;391(6669):815-8. doi: 10.1038/35901.
8
Leukemia with distinct phenotypes in transgenic mice expressing PML/RAR alpha, PLZF/RAR alpha or NPM/RAR alpha.在表达PML/RARα、PLZF/RARα或NPM/RARα的转基因小鼠中具有不同表型的白血病。
Oncogene. 2006 Mar 23;25(13):1974-9. doi: 10.1038/sj.onc.1209216.
9
Retinoic acid, but not arsenic trioxide, degrades the PLZF/RARalpha fusion protein, without inducing terminal differentiation or apoptosis, in a RA-therapy resistant t(11;17)(q23;q21) APL patient.在一名对维甲酸(RA)治疗耐药的t(11;17)(q23;q21)急性早幼粒细胞白血病(APL)患者中,维甲酸而非三氧化二砷可降解PLZF/RARα融合蛋白,且不会诱导终末分化或凋亡。
Oncogene. 1999 Jan 28;18(4):1113-8. doi: 10.1038/sj.onc.1202414.
10
AML-1/ETO fusion protein is a dominant negative inhibitor of transcriptional repression by the promyelocytic leukemia zinc finger protein.AML-1/ETO融合蛋白是早幼粒细胞白血病锌指蛋白转录抑制的显性负性抑制剂。
Blood. 2000 Dec 1;96(12):3939-47.

引用本文的文献

1
Function of PML-RARA in Acute Promyelocytic Leukemia.PML-RARA 在急性早幼粒细胞白血病中的作用。
Adv Exp Med Biol. 2024;1459:321-339. doi: 10.1007/978-3-031-62731-6_14.
2
Noncanonical EZH2 drives retinoic acid resistance of variant acute promyelocytic leukemias.非经典EZH2驱动变异型急性早幼粒细胞白血病的维甲酸耐药性。
Blood. 2022 Dec 1;140(22):2358-2370. doi: 10.1182/blood.2022015668.
3
A novel RARA-SNX15 fusion in PML-RARA-positive acute promyelocytic leukemia with t(11;17;15)(q13;q21.2;q24.1).在伴有t(11;17;15)(q13;q21.2;q24.1)的PML-RARA阳性急性早幼粒细胞白血病中发现一种新型RARA-SNX15融合基因。
Int J Hematol. 2022 Dec;116(6):956-960. doi: 10.1007/s12185-022-03421-w. Epub 2022 Jul 19.
4
Engineering chromosome rearrangements in cancer.在癌症中工程染色体重排。
Dis Model Mech. 2021 Sep 1;14(9). doi: 10.1242/dmm.049078. Epub 2021 Sep 29.
5
Emerging Cancer Epigenetic Mechanisms Regulated by All-Trans Retinoic Acid.全反式维甲酸调控的新兴癌症表观遗传机制
Cancers (Basel). 2020 Aug 14;12(8):2275. doi: 10.3390/cancers12082275.
6
Classic and Variants APLs, as Viewed from a Therapy Response.从治疗反应角度看经典型和变异型急性早幼粒细胞白血病
Cancers (Basel). 2020 Apr 14;12(4):967. doi: 10.3390/cancers12040967.
7
Differentiation therapy revisited.重新审视分化治疗。
Nat Rev Cancer. 2018 Feb;18(2):117-127. doi: 10.1038/nrc.2017.103. Epub 2017 Dec 1.
8
Eya2, a Target Activated by Plzf, Is Critical for -Induced Leukemogenesis.Eya2是一种由Plzf激活的靶点,对诱导白血病发生至关重要。
Mol Cell Biol. 2017 Jun 15;37(13). doi: 10.1128/MCB.00585-16. Print 2017 Jul 1.
9
Somatic Engineering of Oncogenic Chromosomal Rearrangements: A Perspective.致癌染色体重排的体细胞工程:一种观点
Cancer Res. 2016 Sep 1;76(17):4918-23. doi: 10.1158/0008-5472.CAN-16-0726. Epub 2016 Aug 12.
10
Regulation of hematopoietic development by ZBTB transcription factors.ZBTB转录因子对造血发育的调控
Int J Hematol. 2016 Sep;104(3):310-23. doi: 10.1007/s12185-016-2035-x. Epub 2016 Jun 1.